These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20568894)

  • 1. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
    Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
    Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
    Fialova B; Smesny Trtkova K; Paskova L; Langova K; Kolar Z
    Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
    Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
    Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants.
    Korkmaz CG; Frønsdal K; Zhang Y; Lorenzo PI; Saatcioglu F
    J Endocrinol; 2004 Sep; 182(3):377-89. PubMed ID: 15350180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor signaling: mechanism of interleukin-6 inhibition.
    Jia L; Choong CS; Ricciardelli C; Kim J; Tilley WD; Coetzee GA
    Cancer Res; 2004 Apr; 64(7):2619-26. PubMed ID: 15059919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
    Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD; Gleave ME
    Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S; Guerardel C; Leprince D
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
    Ren G; Zhang G; Dong Z; Liu Z; Li L; Feng Y; Su D; Zhang Y; Huang B; Lu J
    Int J Biochem Cell Biol; 2009 May; 41(5):1094-101. PubMed ID: 19013255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
    Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
    Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effect of sodium butyrate on cancer and normal prostate cells.
    Paskova L; Smesny Trtkova K; Fialova B; Benedikova A; Langova K; Kolar Z
    Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
    Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
    Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors.
    Pan C; Wang Q; Liu YP; Xu LF; Li YF; Hu JX; Jiang M; Zhang JP; Zhang MR; Yu HM; Zhou JL; Zhou XL; Xu LC
    Toxicology; 2013 Sep; 311(3):178-83. PubMed ID: 23831764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.
    Ai J; Wang Y; Dar JA; Liu J; Liu L; Nelson JB; Wang Z
    Mol Endocrinol; 2009 Dec; 23(12):1963-72. PubMed ID: 19855091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K; Saatcioglu F
    Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.